Azelastine Hydrochloride Spray, Metered
Product Images NDC 60505-0833

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 60505-0833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figurea.jpg (Figurea)

FDA Label Image

Figureb.jpg (Figureb)

FDA Label Image

Figurec.jpg (Figurec)

FDA Label Image

Figured.jpg (Figured)

FDA Label Image

Figuree.jpg (Figuree)

FDA Label Image

Figuref-and-g.jpg (Figuref And G)

FDA Label Image

Lbl30ml

Lbl30ml
This is a description of a nasal spray called "0SEE8050S" manufactured by Apotex Corp. The nasal spray contains azelastine hydrochloride and benzalkonium chloride as preservative. The solution is to be used intranasally and is not to be sprayed in the eye. The initial priming is 4 sprays, and to re-prime, 2 sprays should be used or until a fine mist appears. The bottle should be stored upright at a controlled room temperature to protect from freezing. The accompanying full prescribing information should be carefully read before use. The product contains 200 metered sprays and delivers 137 micrograms of azelastine hydrochloride per spray.*
FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.